EFFECTS OF VESTIBULAR REHABILITATION THERAPY (VRT) ON BALANCE, SPEED AND AGILITY IN POST-CONCUSSION FOOTBALL PLAYERS

July 23, 2020 updated by: Syed Alamdar Hussain, Zohra Institute of Health Sciences
Traumatic brain injury (TBI) is one and utmost rampant attained neurological conditions which can happen in young adults. Vestibular Rehabilitation Therapy can help them improve their balance, speed and agility.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Total 40 sample size out of which were divided into control and experimental group. Concussed football athletes with age ranging 15-25 year, those participating actively in the sports were included in the study in the region of Kyber Pukhtoonkhwa Peshawar.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • KP
      • Peshawar, KP, Pakistan, 25000
        • Syed Alamdar Hussain

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 21 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

Active Male football player. Age between 15-25 years. Known cases of concussion were included in the study. Those patients complaining mild vertigo & participating in sports

Exclusion Criteria:

Concussion other than sports. History of metabolic diseases. History of recent fractures.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental Group

Subjects were randomly assigned and informed consent was obtained, the subjects were educated about treatment. This contained 4 types of progressive activities. Respectively every type contains 2 to 4 tasks, performed in sets of 10 repetitions for 4 weeks.

Results were obtained by using Balance scoring system, and physical performance test for speed and agility

Activity sitting on the "Exercise Ball" swing (eye movements, first slow and then fast)

Swing sitting activity (head movements, first slow then fast - eyes open and eyes closed)

Trunk activities focusing on balance

Dynamic balance activity focusing on standing

No Intervention: Control Group

Control group: (Group B) Subjects were randomly assigned and informed consent was obtained, the subjects were educated about treatment. They were asked to perform the regular drills.

Results were obtained using Balance Error scoring system and physical performance test for speed and agility.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Balance
Time Frame: upto 8 weeks
Balance Error Scoring System (BESS) which us used to evaluate the balance of the athlete
upto 8 weeks
Agility
Time Frame: upto 8 weeks
30 Ft Agility Shuttle Run which is used to evaluate agility of athletes
upto 8 weeks
Speed
Time Frame: upto 8 weeks
30 Meter dash which is used to evaluate the speed of the athlete
upto 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2020

Primary Completion (Actual)

February 28, 2020

Study Completion (Actual)

February 28, 2020

Study Registration Dates

First Submitted

July 23, 2020

First Submitted That Met QC Criteria

July 23, 2020

First Posted (Actual)

July 27, 2020

Study Record Updates

Last Update Posted (Actual)

July 27, 2020

Last Update Submitted That Met QC Criteria

July 23, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe